- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00715130
Move and Moderate in Balance (MOVE'M)
Move and Moderate in Balance (MOVE'M): A TREC Worksite Health Study
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Our overall objective is to develop and evaluate an intervention that will maintain or decrease body mass index; specifically, we will recruit and randomize 30 worksites to a two year intervention in which we will:
- Influence the worksite environment, including policies and procedures, by increasing worksite access to healthy foods and physical activity opportunities
- Promote individual behavior change, through increasing awareness of energy balance; building a physical activity intervention that will promote increased levels of energy expenditure through the combination of increased daily physical activity and regular, structured exercise; and building a dietary intervention that will promote decreased calorie intake.
Our primary aim is to:
1) Evaluate the effectiveness of the intervention in reducing or maintaining body mass index in a randomized controlled trial of worksites.
Our secondary aims are to:
- Assess changes in worksite environment in access to healthy foods and physical activity opportunities attributable to the intervention
- Assess changes in individual level physical activity and energy intake attributable to the intervention
- Assess the changes in sequalae of weight loss including biomarkers of metabolic effects, and weight loss quality of life and symptom measures; and
- Estimate the cost-effectiveness of the intervention in controlling weight.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Washington
-
Seattle, Washington, Forente stater, 98109
- Fred Hutchinson Cancer Research Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Employees of the enrolled worksite who are 18 years or older and work at the company at least 50% FTE (20 hrs per week)
Exclusion Criteria:
- Any employees of the enrolled worksite who are interns or seasonal workers or employees who work less than 50% FTE (20 hrs per week)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Our main outcome measure is change in body mass index, as an aggregated value at the worksite level.
Tidsramme: At study conclusion
|
At study conclusion
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Secondary, process measures will be of physical activity, physical fitness and calorie intake, at the individual level, within worksites.
Tidsramme: At study conclusion
|
At study conclusion
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Shirley AA Beresford, PhD, Fred Hutchinson Cancer Center
- Studieleder: Anne McTiernan, MD, PhD, Fred Hutchinson Cancer Center
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- FHCRC-6334
- U54CA116847 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .